THE HEMP AND HEMP-DERIVED CBD CONSUMER PROTECTION & MARKET STABILIZATION ACT OF 2021
This bill allows the use of hemp, cannabidiol (i.e., CBD) derived from hemp, or any other ingredient derived from hemp in a dietary supplement, provided that the supplement meets other applicable requirements. (Currently, the Food and Drug Administration's position is that CBD products may not be sold as dietary supplements.)
Why support H.R. 841?
For years, hemp farmers, small businesses and CBD consumers have been struggling due to the failure of the FDA to legally recognize and regulate the sale of hemp-derived CBD products. Regulatory uncertainty has led to a sharp decline in hemp prices and economic hardship for hemp farmers. Meanwhile, a multitude of CBD products continue to be sold, some of which raise significant quality, safety and other consumer protection concerns.
What would H.R. 841 do?
H.R. 841 would ensure that hemp-derived CBD, and other non-intoxicating hemp ingredients, could be lawfully marketed as dietary supplements. The bill would require CBD and hemp extract product manufacturers to comply with the entire existing comprehensive regulatory framework for dietary supplements, which ensures that the products are deemed safe, properly labeled, and prepared utilizing Good Manufacturing Practices. Passage would also help stabilize the hemp markets, open up a promising economic opportunity for U.S. agriculture and honor our commitment made to farmers in the 2018 Farm Bill.